Aller au contenu principal
Profil bibliographique

Thomas D. Jensen

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

45Publications signalées
1570Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Consumer Behavior in Brand Consumption and IdentificationConsumer Market Behavior and PricingProstate Cancer Treatment and ResearchDigital Marketing and Social MediaManagement and Marketing Education

Les publications récentes

Accès ouvert 2023 article OpenAlex

Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

Alexander Dias, Mark N. Brook, Elizabeth Bancroft, Elizabeth Page et autres

Abstract Objectives The relation of serum androgens and the development of prostate cancer (PCa) is subject of debate. Lower total testosterone (TT) levels have been associated with increased PCa detection and worse pathological features after treatment. However, data from the Reduction by …

gb, br, dk, pl, se, my (code pays fourni par la source)

6 citations BJUI Compass
Accès ouvert 2019 article OpenAlex

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Vivek Patel, Evan L. Busch, Tara M. Friebel, Angel M. Cronin et autres

Abstract Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using …

us, gb, it, is, fi, ca, de, se, es, fr, dk, nl, hu, au, hk, be, pl, cz, gr (code pays fourni par la source)

53 citations Cancer Research
Accès ouvert 2019 article OpenAlex

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Elizabeth Page, Elizabeth Bancroft, Mark N. Brook, Melissa Assel et autres

BACKGROUND: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. OBJECTIVE: To report the utility of PSA screening, PrCa incidence, positive …

gb, ca, us, se, no, au, nl, dk, pl, es, de, pt, il, si, ie, is, it, in, my (code pays fourni par la source)

246 citations European Urology
Accès ouvert 2018 erratum OpenAlex

Erratum: Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Christos Mikropoulos, Christina G. Selkirk, Sibel Saya, Elizabeth Bancroft et autres

Correction to: British Journal of Cancer (2018) 118, 266–276; doi:10.1038/bjc.2017.429; published online 04 January 2018 The authors would like to acknowledge the following information for this manuscript: Christos Mikropoulos and Christina G Hutten Selkirk are joint first authors of this manuscript. Brian …

5 citations British Journal of Cancer
Accès ouvert 2018 article OpenAlex

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Christos Mikropoulos, Christina G. Selkirk, Sibel Saya, Elizabeth Bancroft et autres

BACKGROUND: Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic predisposition to PrCa due to BRCA1/2 mutations. This analysis evaluates …

gb, us, no, au, dk, nl, pl, es, pt, de, ca, se, il, si, ps, ie, is, it, in, my (code pays fourni par la source)

20 citations British Journal of Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.